WHERE INNOVATION IGNITES HOPE

Serial Number 99426403
630

Registration Progress

Application Filed
Oct 3, 2025
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

WHERE INNOVATION IGNITES HOPE

Basic Information

Serial Number
99426403
Filing Date
October 3, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
630
Status Date
Oct 3, 2025
Application
Pending
Classes
042

Rights Holder

Natsar Pharmaceuticals, Inc.

03
Address
4624 Tall Maple Ct.
Ellicott City, MD 21043

Ownership History

Natsar Pharmaceuticals, Inc.

Original Applicant
03
Ellicott City, MD

Legal Representation

Attorney
William A. McComas

Application History

3 events
Date Code Type Description Documents
Oct 3, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Oct 3, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Oct 3, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 042
Medical research; Medical research services; Medical research laboratories; Medical research laboratory services; Providing information about medical research; Providing medical and scientific research information; Pathological testing for medical research purposes; Providing information about medical and scientific research; Medical research in the field of oncology; Medical research in the field of pathology; Medical research in the field of infectious diseases; Medical research services in the field of cancer; Medical research in the field of rare diseases; Providing medical research information in the field of pharmaceuticals; Medical research laboratory services in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Medical and scientific research in the field of cancer treatment and diagnosis; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical testing services and information in the field of cancer research and disease classification; Pharmaceutical drug development services
First Use Anywhere: Sep 3, 2025
First Use in Commerce: Sep 3, 2025

Classification

International Classes
042